Search research articles
Contact Us
Filters
Showing results (91-100 of 188) with videos related to
Page
of 19
Sort By:
Blood
|
November 25, 2010
Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL
Shih-Shih Chen, Rainer Claus, David M Lucas, et al.
British Journal of Haematology
|
July 27, 2012
Complex karyotype predicts for inferior outcomes following reduced-intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia
Samantha M Jaglowski, Amy S Ruppert, Nyla A Heerema, et al.
Leukemia & Lymphoma
|
August 29, 2014
Lower dose of antithymocyte globulin does not increase graft-versus-host disease in patients undergoing reduced-intensity conditioning allogeneic hematopoietic stem cell transplant
Galena Salem, Amy S Ruppert, Patrick Elder, et al.
Cancer Chemotherapy and Pharmacology
|
February 23, 2013
Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancer
Rachel M Layman, Amy S Ruppert, Melinda Lynn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 2022
Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance)
Ann S LaCasce, Travis Dockter, Amy S Ruppert, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 10, 2004
Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genes
Claudia D Baldus, Sandya Liyanarachchi, Krzysztof Mrózek, et al.
Leukemia & Lymphoma
|
February 29, 2012
Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study
Gerard Lozanski, Amy S Ruppert, Nyla A Heerema, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2012
Impact of age on outcomes after initial therapy with chemotherapy and different chemoimmunotherapy regimens in patients with chronic lymphocytic leukemia: results of sequential cancer and leukemia group B studies
Jennifer A Woyach, Amy S Ruppert, Kanti Rai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 22, 2006
Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study
Peter Paschka, Guido Marcucci, Amy S Ruppert, et al.
British Journal of Haematology
|
December 2, 2017
A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor
Kerry A Rogers, Ying Huang, Amy S Ruppert, et al.
Page
of 19
Search research articles
Search
Showing results (91-100 of 188) with videos related to
Sort By:
Page
of 19
Blood
|
November 25, 2010
Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL
Shih-Shih Chen, Rainer Claus, David M Lucas, et al.
British Journal of Haematology
|
July 27, 2012
Complex karyotype predicts for inferior outcomes following reduced-intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia
Samantha M Jaglowski, Amy S Ruppert, Nyla A Heerema, et al.
Leukemia & Lymphoma
|
August 29, 2014
Lower dose of antithymocyte globulin does not increase graft-versus-host disease in patients undergoing reduced-intensity conditioning allogeneic hematopoietic stem cell transplant
Galena Salem, Amy S Ruppert, Patrick Elder, et al.
Cancer Chemotherapy and Pharmacology
|
February 23, 2013
Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancer
Rachel M Layman, Amy S Ruppert, Melinda Lynn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 2022
Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance)
Ann S LaCasce, Travis Dockter, Amy S Ruppert, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 10, 2004
Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genes
Claudia D Baldus, Sandya Liyanarachchi, Krzysztof Mrózek, et al.
Leukemia & Lymphoma
|
February 29, 2012
Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study
Gerard Lozanski, Amy S Ruppert, Nyla A Heerema, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2012
Impact of age on outcomes after initial therapy with chemotherapy and different chemoimmunotherapy regimens in patients with chronic lymphocytic leukemia: results of sequential cancer and leukemia group B studies
Jennifer A Woyach, Amy S Ruppert, Kanti Rai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 22, 2006
Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study
Peter Paschka, Guido Marcucci, Amy S Ruppert, et al.
British Journal of Haematology
|
December 2, 2017
A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor
Kerry A Rogers, Ying Huang, Amy S Ruppert, et al.
Page
of 19